PubMed HealthSearch

PubMed · 1325848

All-ceramic crowns.

Abstract

Despite the good appearance and biocompatibility of dental porcelains, failures are still of considerable concern because of some limited properties common to all-ceramic crown systems. As in the years before, pertinent scientific articles published between November 1990 and December 1991 focused on strengthening mechanisms and compared fracture toughness for different ceramic systems by using various test methods. Some evaluated the clinical implications thereon for seating and loading crowns and measured wear against different ceramic surface conditions. Recently introduced with pleasing aesthetic qualities, IPS-Empress (Ivoclar, Schaan, Liechtenstein), a new European leucite-reinforced glass-ceramic, has finally drawn attention in some journals and has been reviewed with promising in vitro test results. Using a simple press-molding technique, well-fitting crowns, inlays, and veneers can be fabricated without an additional ceramming procedure. Again, only long-term clinical trials will validate achievements compared with other all-ceramic systems and with well-established metal ceramics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C R Lehner, P Schärer. 1992. All-ceramic crowns.. https://pubmed.ncbi.nlm.nih.gov/1325848/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Flow cytometric analysis of macrophage response to ceramic and polyethylene particles: effects of size, concentration, and composition.

Using the J774 macrophage cell line, we designed an in vitro model to analyze by flow cytometry the effects of size, concentration, and composition of ceramic (Al2O3 and ZrO2) and high density polyethylene (HDP) particles on phagocytosis and cell mortality. Inflammatory mediator (TNF-alpha) also was measured by ELISA. Kinetic studies revealed that phagocytosis of the particles begins very early after cell exposure, increasing with time and particle concentration and reaching a plateau after 15 h. This implies that the optimum period to evaluate cellular response to particulate debris is between 15 and 24 h of incubation. Results also showed that phagocytosis increases with concentration for particles up to 2 microns. For larger particles (up to 4.5 microns), phagocytosis seems to reach a plateau independent of size and concentration, which suggests a saturation of phagocytosis that is most likely dependent on overall particle volume ingested. We did not detect any significant difference in phagocytosis between Al2O3 and ZrO2 at 0.6 microns. Al2O3 seems to be more easily phagocytosed than HDP at the same size (4.5 microns) and concentrations. Cytotoxicity studies revealed that macrophage mortality increases with particle size and concentration for sizes greater than 2 microns. Smaller particles (0.6 microns) cause cell mortality only at higher concentrations (from 1,250 particles per cell), but the mortality is still very low (10%). No significant difference in cell mortality and TNF-alpha release was found between Al2O3 and ZrO2. Effects of Al2O3 and HDP at 4.5 microns were compared by measuring TNF-alpha release. Results showed that TNF-alpha release increases with particle concentrations and is higher with HDP than with Al2O3.

Aluminum Oxide

Preparation, characterization, and in vitro release of ibuprofen from AI2O3/PLA/PMMA composites.

The preparation, characterization, and in vitro release of Ibuprofen from Al2O3, poly(L-lactic acid) (PLLA), and polymethylmethacrylate (PMMA) composites are described. The release process of the anti-inflammatory drug after the immersion of composites in a buffered solution is analyzed. The rate of Ibuprofen release is related to the crystalline or amorphous form of the drug. The presence of a ceramic component, alpha-Al2O3, and a biodegradable polymer, PLLA, facilitates both Ibuprofen crystallization and drug release. In addition, these composite systems modulate the release of the stereoisomers R(-) and S(+) of the drug.

Aluminum Oxide

Electrophoretic coating of multilayered apatite composite on alumina ceramics.

By means of an electrophoretic deposition technique followed by sintering, alumina and zirconia ceramics were coated with apatitic composites composed of porous surface and intermediate layers of hydroxyapatite and an adhesive calcium phosphate layer. The electrophoretic deposition of these layers was attained by the use of a mixed solvent of acetylacetone and alcohol as well as the mixed powders of the calcium phosphates and alumina. The adhesive layer was formed by the codeposition of calcium phosphate glass powders (Ca/P = 1/2) with hydroxyapatite, while the open porosity of the surface layer was increased with the addition of alumina to the hydroxyapatite layers. The resultant phases of sintered composite layers were tricalcium phosphate and alumina with a small amount of hydroxyapatite.

Aluminum Oxide